[
  {
    "ts": null,
    "headline": "[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Labor",
    "url": "https://finnhub.io/api/news?id=0a6c28a35cbbb6f1d320ee175862c370baa6af8eae4ccaecd54ba43285e64341",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753115400,
      "headline": "[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136026979,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Labor",
      "url": "https://finnhub.io/api/news?id=0a6c28a35cbbb6f1d320ee175862c370baa6af8eae4ccaecd54ba43285e64341"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT): I Am Very Upset With Abbott,” Says Jim Cramer",
    "summary": "We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT) is a healthcare company. While it was one of Cramer’s top stocks for most of this year, this show saw the CNBC TV host take a different tone. […]",
    "url": "https://finnhub.io/api/news?id=0c3dd6adda82aabbafe31200147479223d6350acf973692bb5121d0a1890c5fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753101837,
      "headline": "Abbott Laboratories (ABT): I Am Very Upset With Abbott,” Says Jim Cramer",
      "id": 136025510,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT) is a healthcare company. While it was one of Cramer’s top stocks for most of this year, this show saw the CNBC TV host take a different tone. […]",
      "url": "https://finnhub.io/api/news?id=0c3dd6adda82aabbafe31200147479223d6350acf973692bb5121d0a1890c5fd"
    }
  },
  {
    "ts": null,
    "headline": "Drugs of Abuse (DoA) Testing Market Opportunities and Strategies to 2034 | Strategic Acquisitions Boost Market Position of Leading DOA Testing Companies",
    "summary": "The global Drugs of Abuse (DOA) testing market is set to grow from $7.29B in 2024 to $16.98B in 2034, driven by healthcare awareness and demand for accurate tests. With North America leading, key growth regions include Asia-Pacific and Eastern Europe. Major players like Abbott are enhancing market strategies with partnerships and innovations, such as mass spectrometry for improved accuracy. Drugs of Abuse (DoA) Testing Market Drugs of Abuse (DoA) Testing Market Dublin, July 21, 2025 (GLOBE NEWSW",
    "url": "https://finnhub.io/api/news?id=36fec2bd165732baf9755d9937ab523f3233870dd0155a95ef187123d4301405",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753092780,
      "headline": "Drugs of Abuse (DoA) Testing Market Opportunities and Strategies to 2034 | Strategic Acquisitions Boost Market Position of Leading DOA Testing Companies",
      "id": 136025511,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The global Drugs of Abuse (DOA) testing market is set to grow from $7.29B in 2024 to $16.98B in 2034, driven by healthcare awareness and demand for accurate tests. With North America leading, key growth regions include Asia-Pacific and Eastern Europe. Major players like Abbott are enhancing market strategies with partnerships and innovations, such as mass spectrometry for improved accuracy. Drugs of Abuse (DoA) Testing Market Drugs of Abuse (DoA) Testing Market Dublin, July 21, 2025 (GLOBE NEWSW",
      "url": "https://finnhub.io/api/news?id=36fec2bd165732baf9755d9937ab523f3233870dd0155a95ef187123d4301405"
    }
  },
  {
    "ts": null,
    "headline": "India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher",
    "summary": "The market's 6.10% CAGR reflects advances in molecular diagnostics, healthcare infrastructure expansion, and personalized medicine. Key trends include companies like Sysmex enhancing local operations and WHO expanding diabetes-related IVDs. Abbott, Qiagen, Quidel, and Danaher lead the market's innovation-driven growth.Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The \"India In Vitro Diagnostics Market Report and Forecast 2025-2034\" has been added to ResearchAndMarkets.com's offering. The India in vi",
    "url": "https://finnhub.io/api/news?id=c3fe12143e94572101f067ab25576a9d9b1c1c7f6a7dee2a03a6918bd22fd52f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753092120,
      "headline": "India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher",
      "id": 136024321,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The market's 6.10% CAGR reflects advances in molecular diagnostics, healthcare infrastructure expansion, and personalized medicine. Key trends include companies like Sysmex enhancing local operations and WHO expanding diabetes-related IVDs. Abbott, Qiagen, Quidel, and Danaher lead the market's innovation-driven growth.Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The \"India In Vitro Diagnostics Market Report and Forecast 2025-2034\" has been added to ResearchAndMarkets.com's offering. The India in vi",
      "url": "https://finnhub.io/api/news?id=c3fe12143e94572101f067ab25576a9d9b1c1c7f6a7dee2a03a6918bd22fd52f"
    }
  },
  {
    "ts": null,
    "headline": "Cote d'Ivoire IVD Market Forecast Report 2025-2032 | Opportunities in Public-Private Partnerships, Molecular Diagnostics Demand, Telemedicine and Point-of-Care Testing",
    "summary": "The Côte d’Ivoire IVD market is poised for growth with the increasing prevalence of infectious diseases, government support, and technological advancements in diagnostics. Key players include Abbott, Roche, and Siemens. The market segments by offerings into reagents, instruments, and services, with reagents poised to dominate due to the high rate of infectious diseases like malaria and HIV. By technology, glucose monitoring is expected to see the highest growth due to rising diabetes awareness.",
    "url": "https://finnhub.io/api/news?id=dd22c8932ea8efe2cbc0d1c9081c4cf62b984d1c423be3b87298e68a59915f11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753089720,
      "headline": "Cote d'Ivoire IVD Market Forecast Report 2025-2032 | Opportunities in Public-Private Partnerships, Molecular Diagnostics Demand, Telemedicine and Point-of-Care Testing",
      "id": 136023646,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Côte d’Ivoire IVD market is poised for growth with the increasing prevalence of infectious diseases, government support, and technological advancements in diagnostics. Key players include Abbott, Roche, and Siemens. The market segments by offerings into reagents, instruments, and services, with reagents poised to dominate due to the high rate of infectious diseases like malaria and HIV. By technology, glucose monitoring is expected to see the highest growth due to rising diabetes awareness.",
      "url": "https://finnhub.io/api/news?id=dd22c8932ea8efe2cbc0d1c9081c4cf62b984d1c423be3b87298e68a59915f11"
    }
  },
  {
    "ts": null,
    "headline": "Kenya IVD Market Research Report 2025-2032 | Opportunities in Increasing Adoption of Self-testing Kits, Emerging Technologies, Shift Towards Personalized Medicine, Integration of Digital Health",
    "summary": "The Kenya in vitro diagnostics (IVD) market is set for significant growth, driven by a high incidence of infectious diseases like HIV, TB, and malaria, government health initiatives, and increasing demand for quality diagnostics. Key players include Abbott Laboratories, Siemens Healthineers, and Roche. In 2025, the reagents & kits segment is expected to dominate, boosted by the prevalence of infectious and chronic diseases in Kenya. The whole blood glucose monitoring segment is forecasted to exh",
    "url": "https://finnhub.io/api/news?id=f60d8e828a5fc29323c58ab4bb110d1a8fbbeef5b8b29a4757e049a47f096924",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753089600,
      "headline": "Kenya IVD Market Research Report 2025-2032 | Opportunities in Increasing Adoption of Self-testing Kits, Emerging Technologies, Shift Towards Personalized Medicine, Integration of Digital Health",
      "id": 136023647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Kenya in vitro diagnostics (IVD) market is set for significant growth, driven by a high incidence of infectious diseases like HIV, TB, and malaria, government health initiatives, and increasing demand for quality diagnostics. Key players include Abbott Laboratories, Siemens Healthineers, and Roche. In 2025, the reagents & kits segment is expected to dominate, boosted by the prevalence of infectious and chronic diseases in Kenya. The whole blood glucose monitoring segment is forecasted to exh",
      "url": "https://finnhub.io/api/news?id=f60d8e828a5fc29323c58ab4bb110d1a8fbbeef5b8b29a4757e049a47f096924"
    }
  }
]